Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil

BMC Public Health

Volumn 2, Issue , 2002, Pages 1-5

  Lewis Ximenez, Lia L ^a,b   Do Ó, Kycia M R ^a   Ginuino, Cleber F ^a   Silva, Jucimara C ^a   Schatzmayr, Hermann G ^a   Stuver, Sherri ^b   Yoshida, Clara F T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; ILLICIT DRUG; BIOLOGICAL MARKER; HEPATITIS ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; EXPOSURE; FEMALE; HEPATITIS B; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYGAMY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; ADDICTION; BLOOD; BLOODBORNE BACTERIUM; CROSS-SECTIONAL STUDY; HEALTH; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; SAFE SEX; SEX RATIO; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; BLOOD-BORNE PATHOGENS; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SAFE SEX; SEX DISTRIBUTION; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH; VACCINATION;

EID: 3342891176     PISSN: 14712458     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2458-2-26     Document Type: Article

References (18)

1. Maynard JE, Kane MA, Hadler SC: Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989, 11(suppl 3):S574-S578
2. Wu JS, Hwang LY, Goodman KJ, Beasley RP: Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999, 179:1319-1325
3. Da Villa G: Rationale for the infant and adolescent vaccination programmes in Italy. Vaccine 2000, 18(suppl 1):S31-S34
4. Huang K, Lin S: Nationwide vaccination: A success story in Taiwan. Vaccine 2000, 18(suppl 1):S35-S38
5. Mulley AG, Silverstein MD, Dienstag JL: Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis, N Engl J Med 1982, 307:644-652
6. Lahaye D, Strauss P, Baleux C, van Ganse W: Cost-benefit analysis of hepatitis-B vaccination, Lancet 1987, 2:441-443
7. Skov T, Deddens J, Petersen MR, Endahl L: Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol 1998, 27:91-95
8. Juarez E, do Amaral Junior C, Pinheiro F, Biellik R: Hepatitis B and delta vaccination program in the western Amazon region of Brazil. Prog Clin Biol Res 1991, 364:343-349
9. Martelli CMT, Turchi MD, Souto FJ, Sáez-Alquézar A, Andrade ALSS, Zicker F: Anti-HBc testing for blood donors in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 1999, 6:69-73
10. Silveira TR, da Fonseca JC, Rivera L, et al: Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 1999, 6:378-383
11. Ministério da Saúde/Fundação Nacional da Saúde/CENEPI/Vigilância Epidemiológica: [http://www.saude. gov.br/inform/idb97/morbid/D01/d01h.htm]
12. Szmuness W, Harley EJ, Ikram H, Stevens CE: Sociodemographic aspects of the epidemiology of hepatitis B. In: Viral hepatitis (Edited by: Vyas GN, Cohen SN, Schmid R) Philadelphia: Franklin Institute Press 1978, 279-320
13. Szmuness W, Much I, Prince AM, et al: On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med 1975, 83:489-495
14. Nordenfelt E, Lindholm T, Dahlquist E: A hepatitis epidemic in a dialysis unit. Occurrence and persistence of Australia-antigen among patients and staff. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1970, 78:692-700
15. Knight AH, Fox RA, Baillod RA, Niazi SP, Sherlock S, Moorhead JF: Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J 1970, 3:603-606
16. Seow SS: Hepatitis in drug dependents. Aust Fam Physician 1981, 10:294, 296, 298
17. Favero MS, Bond WW, Petersen NJ, Berquist KR, Maynard JE: Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis 1974, 129:210-212.
18. Lewis-Ximenes LL, Oliveira JM, Mercadante LAC, et al: Serological and Vaccination Profile of Hemodialysis Patients during an Outbreak of Hepatitis B Virus Infection. Nephron 2001, 87:19-26